Before 1980, colorectal cancer death rates were actually higher for whites than African Americans.

But, as rates began falling in the 1980′s for both blacks and white patients, decreases for whites were substantially greater than those for blacks.  Between 1985 and 2008, mortality rates for whites with colorectal cancer fell 40 percent, while black rates declined by less than 20 percent.

The decrease in black death rates was higher than those for whites at every stage at diagnosis, but strikingly different when cancer had spread to distant sites.   For whites whose colon or rectal cancer was first found at stage IV, death rates fell by more than 30 percent, while black rates declined by less than 5 percent.

Over time, five year survival after regional and distant diagnoses grew for white patients but remained essentially unchanged for blacks. Read the rest of this entry »

Colorectal cancer screening rates for colorectal cancer improved between 2000 and 2008 for white, black and Asian-Americans aged 50 and over—but barely improved for Hispanics and actually worsed for American Indians and Alaska Natives.

The latest statistics, just reported by the federal Agency for Healthcare Research and Quality on March 23, found that:

• In 2008, among adults aged 50 or over, about 60 percent of whites reported ever having been screened (up from 51 percent in 2000);
• About 55 percent of blacks and Asian Americans had been screened at least once (compared to 44 percent in 2000);
• In the same age group, only 44 percent of Hispanics reported ever having been screened (slightly increased from just 35 percent in 2000), even though this population has the third-highest death rate from colorectal cancer;
• Screening rates actually decreased among American Indians and Alaska Natives, to only 37 percent in 2008 (compared to 41 percent in 2000).

Among people without health insurance, screening rates were significantly lower in all ethnic groups:

• Among both whites and blacks with no health insurance, the at-least-once screening rate was about 30 percent (increased barely from 26% in 2000);
• Screening worsened to an abysmal 13 percent (down from 16 percent in 2000) among Hispanics with no health insurance.

In summary, even among those with insurance, only half—and often far fewer—people over age 50 are getting even one screening. Among the uninsured, screening is just not being done for a cancer that can be prevented or cured if caught early.

Source: Agency for Healthcare Research and Quality, 2010 National Healthcare Quality and Disparities Reports

Overall, colorectal cancer screening rates were higher in 2008 than in 2006.

By 2008 almost 2 of every 3 Americans over the age of 50 had either had a fecal occult blood test in the past year or sigmoidoscopy or colonoscopy within the past ten years.

Health insurance made a huge different with two-thirds (66.6 percent) of people with insurance up-to-date with screening compared to about one-third (37.5 percent) of those without health insurance. Read the rest of this entry »

How many more lives could we save if we simply delivered, consistently, the things that work?

That was the challenge that Dr. Arthur Kellerman laid down to people attending the AACR Science of Cancer Health Disparities conference in Miami on September 30.

Dr. Kellerman, an emergency room physician, told a sobering story of his patient Diane, who arrived in the emergency room in pain.  Asked to describe what hurt, she pointed to her right breast.  When her gown was lifted, doctors and nurses could see a huge cancer that had broken through her skin.  Uninsured, she had tried to treat it with over-the-counter salves. She died two months later.

He said that, like Diane, 1000 Americans die every week because they don’t get health care that meets medical standards. Read the rest of this entry »

Insurance makes a difference for people with rectal cancer.

Rectal cancer patients without insurance or covered by Medicaid are almost twice as likely to die within five years as those privately insured.

Not only are they diagnosed at a later stage, but fewer receive recommended treatments at every stage.

More than half of the difference between patients with private insurance and those without was due to differences in how early they were diagnosed and whether or not they got standard treatment. Read the rest of this entry »